Catalyst Pharmaceuticals Announces Second Quarter 2017 Financial Results and Provides Corporate Update

Go back to Catalyst Pharmaceuticals Announces Second Quarter 2017 Financial Results and Provides Corporate Update

Catyalyst Pharma (CPRX) Tops Q2 EPS by 1c

August 9, 2017 4:32 PM EDT

Catyalyst Pharma (NASDAQ: CPRX) reported Q2 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.

... More